174 related articles for article (PubMed ID: 35517894)
21. Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling.
Fetoni AR; Paciello F; Mezzogori D; Rolesi R; Eramo SL; Paludetti G; Troiani D
Br J Cancer; 2015 Nov; 113(10):1434-44. PubMed ID: 26469832
[TBL] [Abstract][Full Text] [Related]
22. Indispensable role of mitochondria in maintaining the therapeutic potential of curcumin in acute kidney injury.
Li L; Liu S; Zhou Y; Zhao M; Wang Y; Wang C; Lou P; Huang R; Ma L; Lu Y; Fu P; Liu J
J Cell Mol Med; 2021 Oct; 25(20):9863-9877. PubMed ID: 34532973
[TBL] [Abstract][Full Text] [Related]
23. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance.
Chen Y; Wang L; Zhou J
J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791
[TBL] [Abstract][Full Text] [Related]
24. Human umbilical cord mesenchymal stem cells attenuate cisplatin-induced acute and chronic renal injury.
Peng X; Xu H; Zhou Y; Wang B; Yan Y; Zhang X; Wang M; Gao S; Zhu W; Xu W; Qian H
Exp Biol Med (Maywood); 2013 Aug; 238(8):960-70. PubMed ID: 23970411
[TBL] [Abstract][Full Text] [Related]
25. Acetaminophen enhances cisplatin- and paclitaxel-mediated cytotoxicity to SKOV3 human ovarian carcinoma.
Wu YJ; Neuwelt AJ; Muldoon LL; Neuwelt EA
Anticancer Res; 2013 Jun; 33(6):2391-400. PubMed ID: 23749887
[TBL] [Abstract][Full Text] [Related]
26. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment.
Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z
Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA 1301 inhibits cisplatin resistance in human ovarian cancer cells by regulating EMT and autophagy.
Yu JL; Gao X
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1688-1696. PubMed ID: 32141535
[TBL] [Abstract][Full Text] [Related]
28. PGC-1α alleviates mitochondrial dysfunction via TFEB-mediated autophagy in cisplatin-induced acute kidney injury.
Yuan L; Yuan Y; Liu F; Li L; Liu J; Chen Y; Cheng J; Lu Y
Aging (Albany NY); 2021 Mar; 13(6):8421-8439. PubMed ID: 33714196
[TBL] [Abstract][Full Text] [Related]
29. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
[TBL] [Abstract][Full Text] [Related]
30. Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.
Fan WH; Wang FC; Jin Z; Zhu L; Zhang JX
Curr Med Sci; 2022 Feb; 42(1):108-117. PubMed ID: 34958454
[TBL] [Abstract][Full Text] [Related]
31. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells.
Wahl H; Tan L; Griffith K; Choi M; Liu JR
Gynecol Oncol; 2007 Apr; 105(1):104-12. PubMed ID: 17174384
[TBL] [Abstract][Full Text] [Related]
32. Tolerance to endoplasmic reticulum stress mediates cisplatin resistance in human ovarian cancer cells by maintaining endoplasmic reticulum and mitochondrial homeostasis.
Xu Y; Wang C; Su J; Xie Q; Ma L; Zeng L; Yu Y; Liu S; Li S; Li Z; Sun L
Oncol Rep; 2015 Dec; 34(6):3051-60. PubMed ID: 26398138
[TBL] [Abstract][Full Text] [Related]
33. Paracrine Activation of the Wnt/β-Catenin Pathway by Bone Marrow Stem Cell Attenuates Cisplatin-Induced Kidney Injury.
Jiao X; Cai J; Yu X; Ding X
Cell Physiol Biochem; 2017; 44(5):1980-1994. PubMed ID: 29237155
[TBL] [Abstract][Full Text] [Related]
34. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth.
Yallapu MM; Maher DM; Sundram V; Bell MC; Jaggi M; Chauhan SC
J Ovarian Res; 2010 Apr; 3():11. PubMed ID: 20429876
[TBL] [Abstract][Full Text] [Related]
35. Mitochondria-mediated mitigatory role of curcumin in cisplatin-induced nephrotoxicity.
Waseem M; Kaushik P; Parvez S
Cell Biochem Funct; 2013 Dec; 31(8):678-84. PubMed ID: 23408677
[TBL] [Abstract][Full Text] [Related]
36. Pre-Treatment with Curcumin Ameliorates Cisplatin-Induced Kidney Damage by Suppressing Kidney Inflammation and Apoptosis in Rats.
Soetikno V; Sari SDP; Ul Maknun L; Sumbung NK; Rahmi DNI; Pandhita BAW; Louisa M; Estuningtyas A
Drug Res (Stuttg); 2019 Feb; 69(2):75-82. PubMed ID: 29945277
[TBL] [Abstract][Full Text] [Related]
37. Curcumin Acts as a Chemosensitizer for Leiomyosarcoma Cells In Vitro But Fails to Mediate Antioxidant Enzyme Activity in Cisplatin-Induced Experimental Nephrotoxicity in Rats.
Dhima I; Zerikiotis S; Lekkas P; Simos YV; Gkiouli M; Vezyraki P; Dounousi E; Ragos V; Giannakopoulos X; Baltogiannis D; Kalfakakou V; Evangelou A; Peschos D; Karkabounas S
Integr Cancer Ther; 2019; 18():1534735419872811. PubMed ID: 31441361
[No Abstract] [Full Text] [Related]
38. Induction of microRNA-9 mediates cytotoxicity of curcumin against SKOV3 ovarian cancer cells.
Zhao SF; Zhang X; Zhang XJ; Shi XQ; Yu ZJ; Kan QC
Asian Pac J Cancer Prev; 2014; 15(8):3363-8. PubMed ID: 24870723
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents.
Chan MM; Fong D; Soprano KJ; Holmes WF; Heverling H
J Cell Physiol; 2003 Jan; 194(1):63-70. PubMed ID: 12447990
[TBL] [Abstract][Full Text] [Related]
40. Curcumin ameliorates cisplatin-induced cystopathy via activating NRF2 pathway.
Shao YP; Zhou Q; Li YP; Zhang SC; Xu HW; Wu S; Shen BX; Ding LC; Xue J; Chen ZS; Wei ZQ
Neurourol Urodyn; 2018 Nov; 37(8):2470-2479. PubMed ID: 29917258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
